ZA952056B - Expression plasmids regulated by an osmB promoter - Google Patents
Expression plasmids regulated by an osmB promoterInfo
- Publication number
- ZA952056B ZA952056B ZA952056A ZA952056A ZA952056B ZA 952056 B ZA952056 B ZA 952056B ZA 952056 A ZA952056 A ZA 952056A ZA 952056 A ZA952056 A ZA 952056A ZA 952056 B ZA952056 B ZA 952056B
- Authority
- ZA
- South Africa
- Prior art keywords
- expression plasmids
- osmb promoter
- regulated
- plasmids
- osmb
- Prior art date
Links
- 101150004298 osmB gene Proteins 0.000 title abstract 2
- 239000013613 expression plasmid Substances 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 239000013612 plasmid Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000012440 Acetylcholinesterase Human genes 0.000 abstract 1
- 108010022752 Acetylcholinesterase Proteins 0.000 abstract 1
- 102000019197 Superoxide Dismutase Human genes 0.000 abstract 1
- 108010012715 Superoxide dismutase Proteins 0.000 abstract 1
- 229940022698 acetylcholinesterase Drugs 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/216,851 US5795776A (en) | 1994-03-22 | 1994-03-22 | Expression plasmids regulated by an OSMB promoter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA952056B true ZA952056B (en) | 1995-12-11 |
Family
ID=22808753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA952056A ZA952056B (en) | 1994-03-22 | 1995-03-13 | Expression plasmids regulated by an osmB promoter |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5795776A (fr) |
| EP (1) | EP0764202B1 (fr) |
| JP (2) | JP3878207B2 (fr) |
| AT (1) | ATE386101T1 (fr) |
| AU (1) | AU2126695A (fr) |
| DE (1) | DE69535704T2 (fr) |
| IL (1) | IL113031A (fr) |
| WO (1) | WO1995025785A1 (fr) |
| ZA (1) | ZA952056B (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102161984B (zh) | 1998-08-06 | 2016-06-01 | 山景药品公司 | 分离四聚体尿酸氧化酶的方法 |
| US20040001822A1 (en) * | 2000-12-29 | 2004-01-01 | Avigdor Levanon | Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| US7132510B2 (en) * | 2000-12-29 | 2006-11-07 | Bio-Technology General (Israel) Ltd. | Specific human antibodies for selective cancer therapy |
| US20040002450A1 (en) * | 2000-12-29 | 2004-01-01 | Janette Lazarovits | Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| US20040001839A1 (en) * | 2000-12-29 | 2004-01-01 | Avigdor Levanon | Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| US20040208877A1 (en) * | 2002-07-01 | 2004-10-21 | Avigdor Levanon | Antibodies and uses thereof |
| US20040202665A1 (en) * | 2002-07-01 | 2004-10-14 | Janette Lazarovits | Compositions and methods for therapeutic treatment |
| US20050152906A1 (en) * | 2003-06-30 | 2005-07-14 | Avigdor Levanon | Specific human antibodies |
| US20050266009A1 (en) * | 2003-06-30 | 2005-12-01 | Savient Pharmaceuticals, Inc. | Antibodies and uses thereof |
| US20050069955A1 (en) * | 2003-06-30 | 2005-03-31 | Daniel Plaksin | Antibodies and uses thereof |
| HUE052976T2 (hu) | 2005-04-11 | 2021-06-28 | Horizon Pharma Rheumatology Llc | Urát-oxidáz variáns formái és azok alkalmazása |
| WO2006110761A2 (fr) | 2005-04-11 | 2006-10-19 | Savient Pharmaceuticals, Inc. | Forme de variante d'oxydase d'urate et utilisation associee |
| MX347903B (es) | 2009-06-25 | 2017-05-18 | Crealta Pharmaceuticals Llc | Metodos y equipos para predecir el riesgo de reaccion a la infusion y perdida de respuesta mediada por anticuerpos al supervisar el acido urico en suero durante una terapia con uricasa conjugada con peg. |
| KR101662917B1 (ko) * | 2011-11-25 | 2016-10-06 | 서울대학교산학협력단 | Ｂ형 간염 바이러스 유래 ｃｉｓ-작용 조절 엘리먼트 및 그 용도 |
| PL3380627T3 (pl) | 2015-11-27 | 2020-01-31 | Evonik Degussa Gmbh | Sposób wytwarzania L-metioniny |
| WO2022207543A1 (fr) | 2021-04-01 | 2022-10-06 | Evonik Operations Gmbh | Procédé enzymatique de production du l-glufosinate et de ses phosphoesters |
| EP4105335A1 (fr) | 2021-06-16 | 2022-12-21 | Evonik Operations GmbH | Procédé enzymatique pour la production d'esters p-alkyl du l-glufosinate |
| WO2023174511A1 (fr) | 2022-03-14 | 2023-09-21 | Evonik Operations Gmbh | Procede enzymatique de production de p-esters de l-glufosinate |
| WO2023222227A1 (fr) | 2022-05-19 | 2023-11-23 | Evonik Operations Gmbh | Procédé enzymatique de production de l-glufosinate |
| WO2023222226A1 (fr) | 2022-05-19 | 2023-11-23 | Evonik Operations Gmbh | Procédé enzymatique pour la production de l-glufosinate |
| WO2023232225A1 (fr) | 2022-05-31 | 2023-12-07 | Evonik Operations Gmbh | Procédé enzymatique de production diastéréosélective de p-esters de l-glufosinate |
| WO2024061455A1 (fr) | 2022-09-21 | 2024-03-28 | Evonik Operations Gmbh | Procédé enzymatique de production de l-glufosinate et de ses phosphoesters |
| WO2024061456A1 (fr) | 2022-09-21 | 2024-03-28 | Evonik Operations Gmbh | Procédé enzymatique de production de l-glufosinate et de ses phosphoesters |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4624926A (en) * | 1981-01-02 | 1986-11-25 | The Research Foundation Of State University Of New York | Novel cloning vehicles for polypeptide expression in microbial hosts |
| US4666836A (en) * | 1981-01-02 | 1987-05-19 | The Research Foundation Of State University Of New York | Novel cloning vehicles for polypeptide expression in microbial hosts |
| DK582381A (da) * | 1981-01-02 | 1982-07-03 | Univ New York | Remkombinat plasmid til anvendelse ved bakteriel kloning |
| US4863855A (en) * | 1982-05-14 | 1989-09-05 | The Research Foundation Of State University Of New York | Novel cloning vehicles for polypeptide expression in microbial hosts |
| US4745069A (en) * | 1982-05-25 | 1988-05-17 | Eli Lilly And Company | Cloning vectors for expression of exogenous protein |
| GB2121054B (en) * | 1982-05-25 | 1986-02-26 | Lilly Co Eli | Cloning vectors for expression of exogenous protein |
| JPS59203495A (ja) * | 1983-04-28 | 1984-11-17 | Kyowa Hakko Kogyo Co Ltd | 外来遺伝子の新規な発現方法 |
| US4643969A (en) * | 1983-07-25 | 1987-02-17 | The Research Foundation Of State University Of New York | Novel cloning vehicles for polypeptide expression in microbial hosts |
| US4757013A (en) * | 1983-07-25 | 1988-07-12 | The Research Foundation Of State University Of New York | Cloning vehicles for polypeptide expression in microbial hosts |
| DE3445517C2 (de) * | 1984-12-13 | 1993-11-18 | Ciba Geigy | Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins |
| DK175535B1 (da) * | 1987-03-04 | 2004-11-29 | Daiichi Suntory Pharma Co Ltd | Fremgangsmåde til fremstilling af et fysiologisk aktivt cysteinholdigt peptid |
| US5063158A (en) * | 1987-11-09 | 1991-11-05 | Eli Lilly And Company | Recombinant DNA expression vector comprising both transcriptional and translational activating sequences |
| US5348867A (en) * | 1991-11-15 | 1994-09-20 | George Georgiou | Expression of proteins on bacterial surface |
-
1994
- 1994-03-22 US US08/216,851 patent/US5795776A/en not_active Expired - Lifetime
-
1995
- 1995-03-13 ZA ZA952056A patent/ZA952056B/xx unknown
- 1995-03-19 IL IL113031A patent/IL113031A/en not_active IP Right Cessation
- 1995-03-22 JP JP52481395A patent/JP3878207B2/ja not_active Expired - Lifetime
- 1995-03-22 DE DE69535704T patent/DE69535704T2/de not_active Expired - Lifetime
- 1995-03-22 WO PCT/US1995/003622 patent/WO1995025785A1/fr active IP Right Grant
- 1995-03-22 AT AT95914162T patent/ATE386101T1/de not_active IP Right Cessation
- 1995-03-22 EP EP95914162A patent/EP0764202B1/fr not_active Expired - Lifetime
- 1995-03-22 AU AU21266/95A patent/AU2126695A/en not_active Abandoned
-
1997
- 1997-07-18 US US08/897,043 patent/US5945304A/en not_active Expired - Lifetime
-
2005
- 2005-10-05 JP JP2005292784A patent/JP2006068019A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0764202A1 (fr) | 1997-03-26 |
| JP3878207B2 (ja) | 2007-02-07 |
| DE69535704T2 (de) | 2009-02-12 |
| EP0764202B1 (fr) | 2008-02-13 |
| IL113031A (en) | 2006-07-05 |
| AU2126695A (en) | 1995-10-09 |
| ATE386101T1 (de) | 2008-03-15 |
| DE69535704D1 (de) | 2008-03-27 |
| EP0764202A4 (fr) | 1998-01-07 |
| US5795776A (en) | 1998-08-18 |
| WO1995025785A1 (fr) | 1995-09-28 |
| JPH10500565A (ja) | 1998-01-20 |
| IL113031A0 (en) | 1995-06-29 |
| US5945304A (en) | 1999-08-31 |
| JP2006068019A (ja) | 2006-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL113031A0 (en) | Expression plasmids regulated by an osmb promoter | |
| CA2099841A1 (fr) | Expression de proteines recombinantes dans des bacteries attenuees | |
| AP8600035A0 (en) | Hepatitis B surface antigen formed by recombinant DNA Techniques, vaccines, diagnostics, cell lines and methods of forming same. | |
| EP0263311A3 (fr) | Production du facteur de nécrose de tumeurs par des levures | |
| ES2009907A6 (es) | Procedimiento para detectar en sangre humana la presencia de anticuerpos frente al virus sida. | |
| IL122408A0 (en) | Dna encoding a trail polypeptide and its preparation | |
| HU9603155D0 (en) | Papillomavirus vaccines | |
| AU6733487A (en) | Mammalian interleukin-4 | |
| UA27706C2 (uk) | Спосіб одержання гетерологічного поліпептиду | |
| AU2474892A (en) | Highly stable recombinant yeasts for the production of recombinant proteins | |
| ATE123520T1 (de) | Kex2-endoprotease und verfahren zu ihrer herstellung. | |
| HU9202458D0 (en) | Expressing systems | |
| AU6661490A (en) | Novel polypeptides, the DNA sequences allowing their expression, method of preparation, and utilization | |
| HK140095A (en) | Hepatitis surface antigen particle vaccine | |
| AU2085195A (en) | Gene coding for igg-fc-binding protein | |
| GR3020786T3 (en) | Recombinant DNA expression vectors and DNA compounds that encode isopenicillin N epimerase activity | |
| EP0422217A4 (en) | Human recombinant placental ribonuclease inhibitor and method of production | |
| EP0591548A4 (en) | Anti-hbs antibody gene and expression plasmid thereof | |
| EP0254315A3 (en) | Method for producing peptides | |
| WO2004089973A3 (fr) | Peptides, polypeptides et proteines d'immunogenicite reduite et leurs procedes de production | |
| NZ304789A (en) | Genes encoding lymphocyte interferon regulatory factory (lsirf) polypeptides that are transcription factors and specific antibodies to them | |
| EP0183272A3 (en) | Vector capable of efficient gene expression and utilization of such vector | |
| AU2232297A (en) | Gene that imparts selective proliferative activity | |
| IT1262957B (it) | Procedimento di produzione della proteina sv-iv ricombinante e proteina sv-iv ricombinante. |